47248-0
HIV Antiretroviral therapy Antiretroviral therapy status section
Active
45231-8 HIV treatment prior to enrollment
Term Description
Captures information regarding any previous ART.
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- HIV Rx prior to enrollment
- Property
- Type
- Time
- Pt
- System
- ^Patient
- Scale
- Nom
- Method
- Reported
Additional Names
- Short Name
- HIV Rx prior to enrollment
Basic Attributes
- Class
- ART
- Type
- Clinical
- First Released
- Version 2.17
- Last Updated
- Version 2.67
Normative Answer List LL351-8
Answer | Code | Score | Answer ID |
---|---|---|---|
Currently being treated and transferred in with treatment records from within system. | 1 | LA6517-2 | |
PMTCT only | 2 | LA6518-0 | |
Prior ARV treatment, but not transfer in with records, or client not abel to provide information. | 3 | LA6519-8 | |
None Copyright http://snomed.info/sct ID:260413007 None (qualifier value) | 4 | LA137-2 |
Member of these Panels
LOINC | Long Common Name |
---|---|
47245-6 | HIV treatment form Document |
Copyright
- Organization
- World Health Organization (WHO)
- Copyright
- Copyright © 2006 World Health Organization.
- Terms of Use
- Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.
- URL
- https://www.who.int/about/policies/publishing/copyright
Third Party Copyright
This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.
This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.
Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.
47240-7 Date determined medically eligible to start HIV treatment
Term Description
Date determined medically eligible to start ART
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Date determined medically eligible to start HIV Rx
- Property
- Date
- Time
- Pt
- System
- ^Patient
- Scale
- Qn
- Method
- Reported
Additional Names
- Short Name
- Date eligible to start HIV Rx
Basic Attributes
- Class
- ART
- Type
- Clinical
- First Released
- Version 2.22
- Last Updated
- Version 2.67
- Order vs. Observation
- Observation
Member of these Panels
LOINC | Long Common Name |
---|---|
47245-6 | HIV treatment form Document |
Copyright
- Organization
- World Health Organization (WHO)
- Copyright
- Copyright © 2006 World Health Organization.
- Terms of Use
- Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.
- URL
- https://www.who.int/about/policies/publishing/copyright
45232-6 Reason medically eligible for HIV treatment
Term Description
Why patient is medically eligible for anti-retroviral therapy
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Reason medically eligible for HIV Rx
- Property
- Find
- Time
- Pt
- System
- ^Patient
- Scale
- Nom
- Method
- Reported
Additional Names
- Short Name
- Reason medically eligible for HIV Rx
Basic Attributes
- Class
- ART
- Type
- Clinical
- First Released
- Version 2.17
- Last Updated
- Version 2.67
Normative Answer List LL352-6
Answer | Code | Score | Answer ID |
---|---|---|---|
Clinical Criteria Only | 1 | LA6520-6 | |
CD4 With Or Without Clinical Criteria | 2 | LA6521-4 | |
Clinical Plus TLC | 3 | LA6522-2 |
Member of these Panels
LOINC | Long Common Name |
---|---|
47245-6 | HIV treatment form Document |
Copyright
- Organization
- World Health Organization (WHO)
- Copyright
- Copyright © 2006 World Health Organization.
- Terms of Use
- Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.
- URL
- https://www.who.int/about/policies/publishing/copyright
45233-4 World Health Organization HIV stage
Term Description
Accepted coding values are 1,2,3,4, and T1,T2,T3,T4, both sets basically mean the same thing, the T prefix indicates that the individual is being treated with ARVs.
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- WHO HIV stage
- Property
- Find
- Time
- Pt
- System
- ^Patient
- Scale
- Ord
- Method
- Reported
Additional Names
- Short Name
- WHO HIV stage
Basic Attributes
- Class
- ART
- Type
- Clinical
- First Released
- Version 2.17
- Last Updated
- Version 2.67
Member of these Panels
LOINC | Long Common Name |
---|---|
47245-6 | HIV treatment form Document |
Copyright
- Organization
- World Health Organization (WHO)
- Copyright
- Copyright © 2006 World Health Organization.
- Terms of Use
- Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.
- URL
- https://www.who.int/about/policies/publishing/copyright
32516-7 CD3+CD4+ (T4 helper) cells/100 cells in Specimen
Part Descriptions
LP14441-7 Cells.CD3+CD4+
HIV infection decreases the number of CD3+ CD4+ lymphocytes (also called CD4 T cells or T4 helper cells) while increasing (momentarily) the numbers of CD3+CD8+ lymphocytes (called CD8 T lymphocytes or cytotoxic T cells). Thus the ratio of CD4/CD8 lymphocytes is decreased. These counts are used for prognostic purposes and to guide in the retroviral therapy. CDC has emphasized since 1997 that the number of CD3+ lymphocytes is necessary in addition to the number of CD4+ cells to reliably identify the T4 helper cells and the number of CD8+ cells. Laboratory reports that include only CD4 or only CD8 in their nomenclature are most likely really measuring CD3+CD4+ cells and CD3+CD8+ cells, respectively.
Source: Regenstrief Help
LP14441-7 Cells.CD3+CD4+
HIV infection decreases the number of CD4 T-cells, also called T4 helper cells, the ratio of CD4 to CD8 T-cells and the number of CD8+ T-cells. These counts are ordered frequently to guide decisions about anti-retroviral therapy. Laboratories usually report both percentage and absolute count. When you map CD4 and CD8 markers, be careful! Since at least 1997, CDC has required the detection of both CD3+ and CD4+ to identify T4 helper cells, because the CD3 marker is needed to identify T-cell . So, any tests that report T4 helper cells are really reporting cells that carry BOTH the CD3+ and the CD4+ markers. The measure name may be CD3+ CD4+ cells, CD4+ marker, T4 cells or even just CD4+ (a misnomer). Exactly analogous rules apply to CD8+. Measures that include only CD4 or only CD8 in their name are really measuring CD3+CD4+ cells or CD3+CD8+ cells, respectively and should be reported with the LOINC code that includes both of those markers. The panel named T cell subsets will usually contain both CD3 + CD4 and CD3 + CD8 counts. These names assume that one has already gated to lymphocytes only. Lymphocytes are identified by CD45 markers. So a CD45+CD3+CD4+ is a more complicated way to name CD3+C4+ cells and in the context of looking for CD4 helper T cells they are the same . The same applies to other flow cytometer measures that are looking only at lymphocytes (B-cells, NK cells, etc).
Source: Regenstrief Help
LP14443-3 CD4
Found on helper T-cells; weakly expressed on monocytes.
Associated with some mature T-cell neoplasms, including most cases of T-cell CLL/prolymphocytic leukemia, peripheral
T-cell lymphoma, adult T-cell leukemia/lymphoma and Sézary syndrome/mycosis fungoides
Source: Regenstrief LOINC
Fully-Specified Name
- Component
- Cells.CD3+CD4+/100 cells
- Property
- NFr
- Time
- Pt
- System
- XXX
- Scale
- Qn
- Method
Additional Names
- Short Name
- CD3+CD4+ Cells NFr Spec
- Display Name
- CD3+CD4+ (T4 helper) cells/100 cells (Specimen)
- Consumer Name Alpha Get Info
- CD3+CD4+ (T4 Helper) Cells per 100 cells, Specimen
Basic Attributes
- Class
- CELLMARK
- Type
- Laboratory
- First Released
- Version 2.08
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 6202
Member of these Panels
LOINC | Long Common Name |
---|---|
45270-6 | Acute leukemia panel - Specimen by Flow cytometry (FC) |
45269-8 | Chronic leukemia panel - Specimen by Flow cytometry (FC) |
47245-6 | HIV treatment form Document |
54225-8 | Immune response panel - Specimen by Flow cytometry (FC) |
54229-0 | Lymphoma - T-cell screen panel - Specimen by Flow cytometry (FC) |
54226-6 | Lymphoma panel - Specimen by Flow cytometry (FC) |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
de-DE | German (Germany) | Zellen.CD3+CD4+/100 Zellen: |
es-ES | Spanish (Spain) | Células CD3+CD4+/100 células: Synonyms: Cuantitativo |
es-AR | Spanish (Argentina) | células.CD3+CD4+/100 células: |
es-MX | Spanish (Mexico) | Cells.CD3 + CD4 + / 100 células: |
et-EE | Estonian (Estonia) | Rakud.CD3+CD4+/100 raku kohta: Synonyms: Juhuslik Kvantitatiivne Täpsustamata materjal |
fr-FR | French (France) | CD3+CD4+/100 cellules: |
fr-BE | French (Belgium) | Cellules.CD3+CD4+/100 cellules: |
fr-CA | French (Canada) | Cellules.CD3+CD4+/100 cellules: |
it-IT | Italian (Italy) | Cellule.CD3+CD4+/100 cellule: Synonyms: Cellule CD3 Cellule CD3+CD4+ Cellule CD3-CD4+ Frazione numerica Modelli di superficie cellulare Punto nel tempo (episodio) |
ko-KR | Korean (Korea, Republic Of) | 세포.CD3+CD4+/100 세포: |
nl-NL | Dutch (Netherlands) | cellen.CD3+CD4+/100 cellen: |
pt-BR | Portuguese (Brazil) | Células.CD3+CD4+/100 células: Synonyms: ; |
ru-RU | Russian (Russian Federation) | Клетки.CD3+CD4+/100 клеток: Synonyms: CD3+CD4+ (T4 хэлперы) клетки Количественный Количество отношение Точка во времени; |
tr-TR | Turkish (Turkey) | Hücreler.CD3+CD4+/100 hücre: |
zh-CN | Chinese (China) | 细胞.CD3+CD4+/100 个细胞: Synonyms: CD3+CD4+细胞 CD3-CD4+细胞 CD3细胞 L3T4 Leu3 Leu-3 Leu4; |
Example Units
Unit | Source |
---|---|
% | Example UCUM Units |
% | REGENSTRIEF |
32515-9 CD3+CD4+ (T4 helper) cells [#/volume] in Specimen
Part Descriptions
LP14441-7 Cells.CD3+CD4+
HIV infection decreases the number of CD3+ CD4+ lymphocytes (also called CD4 T cells or T4 helper cells) while increasing (momentarily) the numbers of CD3+CD8+ lymphocytes (called CD8 T lymphocytes or cytotoxic T cells). Thus the ratio of CD4/CD8 lymphocytes is decreased. These counts are used for prognostic purposes and to guide in the retroviral therapy. CDC has emphasized since 1997 that the number of CD3+ lymphocytes is necessary in addition to the number of CD4+ cells to reliably identify the T4 helper cells and the number of CD8+ cells. Laboratory reports that include only CD4 or only CD8 in their nomenclature are most likely really measuring CD3+CD4+ cells and CD3+CD8+ cells, respectively.
Source: Regenstrief Help
LP14441-7 Cells.CD3+CD4+
HIV infection decreases the number of CD4 T-cells, also called T4 helper cells, the ratio of CD4 to CD8 T-cells and the number of CD8+ T-cells. These counts are ordered frequently to guide decisions about anti-retroviral therapy. Laboratories usually report both percentage and absolute count. When you map CD4 and CD8 markers, be careful! Since at least 1997, CDC has required the detection of both CD3+ and CD4+ to identify T4 helper cells, because the CD3 marker is needed to identify T-cell . So, any tests that report T4 helper cells are really reporting cells that carry BOTH the CD3+ and the CD4+ markers. The measure name may be CD3+ CD4+ cells, CD4+ marker, T4 cells or even just CD4+ (a misnomer). Exactly analogous rules apply to CD8+. Measures that include only CD4 or only CD8 in their name are really measuring CD3+CD4+ cells or CD3+CD8+ cells, respectively and should be reported with the LOINC code that includes both of those markers. The panel named T cell subsets will usually contain both CD3 + CD4 and CD3 + CD8 counts. These names assume that one has already gated to lymphocytes only. Lymphocytes are identified by CD45 markers. So a CD45+CD3+CD4+ is a more complicated way to name CD3+C4+ cells and in the context of looking for CD4 helper T cells they are the same . The same applies to other flow cytometer measures that are looking only at lymphocytes (B-cells, NK cells, etc).
Source: Regenstrief Help
LP14443-3 CD4
Found on helper T-cells; weakly expressed on monocytes.
Associated with some mature T-cell neoplasms, including most cases of T-cell CLL/prolymphocytic leukemia, peripheral
T-cell lymphoma, adult T-cell leukemia/lymphoma and Sézary syndrome/mycosis fungoides
Source: Regenstrief LOINC
Reference Information
Type | Source | Reference |
---|---|---|
Mapping Guidance | Regenstrief Help | CD3 as well as CD4 are required to identify CD4 T-cells (CD4 helper cell). Mapper’s Guide for the Top 2000 plus LOINC Laboratory Observations |
Fully-Specified Name
- Component
- Cells.CD3+CD4+
- Property
- NCnc
- Time
- Pt
- System
- XXX
- Scale
- Qn
- Method
Additional Names
- Short Name
- CD3+CD4+ Cells # Spec
- Display Name
- CD3+CD4+ (T4 helper) cells (Specimen) [#/Vol]
- Consumer Name Alpha Get Info
- CD3+CD4+ (T4 Helper) Cells, Specimen
Basic Attributes
- Class
- CELLMARK
- Type
- Laboratory
- First Released
- Version 2.08
- Last Updated
- Version 2.73
- Order vs. Observation
- Observation
- Common Test Rank Get Info
- 1894
Member of these Panels
LOINC | Long Common Name |
---|---|
47245-6 | HIV treatment form Document |
49120-9 | Immunodeficiency follow-up panel - Specimen by Flow cytometry (FC) |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
de-DE | German (Germany) | Zellen.CD3+CD4+: |
es-ES | Spanish (Spain) | Células CD3+CD4+: Synonyms: Cuantitativo |
es-AR | Spanish (Argentina) | células.CD3+CD4+: |
es-MX | Spanish (Mexico) | Células CD3 + CD4 +: |
et-EE | Estonian (Estonia) | Rakud.CD3+CD4+: Synonyms: Juhuslik Kvantitatiivne Täpsustamata materjal |
fr-CA | French (Canada) | Cellules.CD3+CD4+: |
fr-FR | French (France) | CD3+CD4+: |
fr-BE | French (Belgium) | Cellules.CD3+CD4+: |
it-IT | Italian (Italy) | Cellule.CD3+CD4+: Synonyms: Cellule CD3 Cellule CD3+CD4+ Cellule CD3-CD4+ Concentrazione Numerica Modelli di superficie cellulare Punto nel tempo (episodio) |
ko-KR | Korean (Korea, Republic Of) | 세포.CD3+CD4+: |
nl-NL | Dutch (Netherlands) | cellen.CD3+CD4+: |
pt-BR | Portuguese (Brazil) | Células.CD3+CD4+: Synonyms: ; |
ru-RU | Russian (Russian Federation) | Клетки.CD3+CD4+: Synonyms: CD3+CD4+ (T4 хэлперы) клетки Количественный Количество в объеме Точка во времени; |
tr-TR | Turkish (Turkey) | Hücreler.CD3+CD4+: |
uk-UA | Ukrainian (Ukraine) | Клітини.CD3+CD4+: Synonyms: #; |
zh-CN | Chinese (China) | 细胞.CD3+CD4+: Synonyms: CD3+CD4+细胞 CD3-CD4+细胞 CD3细胞 L3T4 Leu3 Leu-3 Leu4; |
Example Units
Unit | Source |
---|---|
/uL | Example UCUM Units |
#/mm3 | REGENSTRIEF |
47241-5 Date determined medically eligible and ready to start HIV treatment
Term Description
Date determined medically eligible and ready to start ART
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Date determined medically eligible and ready to start HIV Rx
- Property
- Date
- Time
- Pt
- System
- ^Patient
- Scale
- Qn
- Method
- Reported
Additional Names
- Short Name
- Date eligible & ready to start HIV Rx
Basic Attributes
- Class
- ART
- Type
- Clinical
- First Released
- Version 2.22
- Last Updated
- Version 2.67
- Order vs. Observation
- Observation
Member of these Panels
LOINC | Long Common Name |
---|---|
47245-6 | HIV treatment form Document |
Copyright
- Organization
- World Health Organization (WHO)
- Copyright
- Copyright © 2006 World Health Organization.
- Terms of Use
- Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.
- URL
- https://www.who.int/about/policies/publishing/copyright
45234-2 Date eligible and selected to start HIV treatment
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Date eligible and selected to start HIV Rx
- Property
- Date
- Time
- Pt
- System
- ^Patient
- Scale
- Qn
- Method
- Reported
Additional Names
- Short Name
- Date eligible & selected to start HIV Rx
Basic Attributes
- Class
- ART
- Type
- Clinical
- First Released
- Version 2.17
- Last Updated
- Version 2.67
Member of these Panels
LOINC | Long Common Name |
---|---|
47245-6 | HIV treatment form Document |
Copyright
- Organization
- World Health Organization (WHO)
- Copyright
- Copyright © 2006 World Health Organization.
- Terms of Use
- Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.
- URL
- https://www.who.int/about/policies/publishing/copyright
45253-2 HIV treatment prior clinic transferred from Address
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- HIV Rx prior clinic transferred from
- Property
- Addr
- Time
- Pt
- System
- Facility
- Scale
- Nom
- Method
- Reported
Additional Names
- Short Name
- HIV Rx prior clinic transferred from Add
Basic Attributes
- Class
- ART
- Type
- Clinical
- First Released
- Version 2.17
- Last Updated
- Version 2.67
Member of these Panels
LOINC | Long Common Name |
---|---|
47245-6 | HIV treatment form Document |
Copyright
- Organization
- World Health Organization (WHO)
- Copyright
- Copyright © 2006 World Health Organization.
- Terms of Use
- Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.
- URL
- https://www.who.int/about/policies/publishing/copyright
45254-0 HIV treatment prior clinic transferred from
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- HIV Rx prior clinic transferred from
- Property
- ID
- Time
- Pt
- System
- Facility
- Scale
- Nom
- Method
- Reported
Additional Names
- Short Name
- HIV Rx prior clinic
Basic Attributes
- Class
- ART
- Type
- Clinical
- First Released
- Version 2.17
- Last Updated
- Version 2.67
Member of these Panels
LOINC | Long Common Name |
---|---|
47245-6 | HIV treatment form Document |
Copyright
- Organization
- World Health Organization (WHO)
- Copyright
- Copyright © 2006 World Health Organization.
- Terms of Use
- Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.
- URL
- https://www.who.int/about/policies/publishing/copyright
45235-9 Date original clinic HIV treatment start
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Date original clinic HIV Rx start
- Property
- Date
- Time
- Pt
- System
- ^Patient
- Scale
- Qn
- Method
- Reported
Additional Names
- Short Name
- Date original clinic HIV Rx start
Basic Attributes
- Class
- ART
- Type
- Clinical
- First Released
- Version 2.17
- Last Updated
- Version 2.67
Member of these Panels
LOINC | Long Common Name |
---|---|
47245-6 | HIV treatment form Document |
Copyright
- Organization
- World Health Organization (WHO)
- Copyright
- Copyright © 2006 World Health Organization.
- Terms of Use
- Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.
- URL
- https://www.who.int/about/policies/publishing/copyright
45236-7 HIV treatment cohort
Term Description
ART start-up group which consists of all patients starting ART in the same month.
Source: Regenstrief LOINC
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- HIV Rx cohort
- Property
- ID
- Time
- Pt
- System
- ^Patient
- Scale
- Nom
- Method
- Reported
Additional Names
- Short Name
- HIV Rx cohort
Basic Attributes
- Class
- ART
- Type
- Clinical
- First Released
- Version 2.17
- Last Updated
- Version 2.67
Member of these Panels
LOINC | Long Common Name |
---|---|
47245-6 | HIV treatment form Document |
Copyright
- Organization
- World Health Organization (WHO)
- Copyright
- Copyright © 2006 World Health Organization.
- Terms of Use
- Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.
- URL
- https://www.who.int/about/policies/publishing/copyright
8671-0 History of Functional status
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Functional status
- Property
- Hx
- Time
- Pt
- System
- ^Patient
- Scale
- Nom
- Method
Additional Names
- Short Name
- Hx of Functional status
Basic Attributes
- Class
- H&P.HX
- Type
- Clinical
- First Released
- Version 1.0h(3)
- Last Updated
- Version 2.56
- Change Reason
- Removed "History of" from Component, changed Property from "Find" to "Hx", and removed "Reported" Method per 8/2015 Clinical LOINC Committee decision
Preferred Answer List LL2963-8
- Externally Defined
- Yes
- Code System
- SCT
- Code System OID
- 1.3.6.1.4.1.12009.10.1.1896
- Link to External List
- http://snomed.info/sct
Member of these Panels
LOINC | Long Common Name |
---|---|
35089-2 | History and physical panel |
47245-6 | HIV treatment form Document |
35090-0 | Patient history |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-MX | Spanish (Mexico) | Estado funcional: |
es-AR | Spanish (Argentina) | antecedentes del estado funcional: |
it-IT | Italian (Italy) | Stato funzionale: Synonyms: Anamnesi paziente Punto nel tempo (episodio) Storia; |
pt-BR | Portuguese (Brazil) | Histórico de condição funcional: Synonyms: ; |
ru-RU | Russian (Russian Federation) | Функциональный статус: Synonyms: История Номинальный; |
zh-CN | Chinese (China) | 功能状态: Synonyms: 分类型应答; |
18833-4 First Body weight
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Body weight
- Property
- Mass
- Time
- Enctr^frst
- System
- ^Patient
- Scale
- Qn
- Method
- Measured
Basic Attributes
- Class
- ATTACH.CLINRPT
- Type
- Claims Attachments
- First Released
- Version 1.0l
- Last Updated
- Version 2.73
- Common Test Rank Get Info
- 17679
Member of these Panels
LOINC | Long Common Name |
---|---|
47245-6 | HIV treatment form Document |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
de-DE | German (Germany) | Körpergewicht: |
es-AR | Spanish (Argentina) | peso corporal: |
fr-FR | French (France) | Poids corporel: |
fr-CA | French (Canada) | Poids: |
it-IT | Italian (Italy) | Peso corporeo: Synonyms: Allegato Allegato referto clinico Incontro; |
nl-NL | Dutch (Netherlands) | lichaamsgewicht: |
pt-BR | Portuguese (Brazil) | Peso corpóreo: Synonyms: ; |
ru-RU | Russian (Russian Federation) | Масса тела: Synonyms: Встреча Количественный |
zh-CN | Chinese (China) | 体重: Synonyms: 临床报告信息附件; |
Example Units
Unit | Source |
---|---|
kg;[lb_av] | Example UCUM Units |
3137-7 Body height Measured
Observation ID in Form
K2a
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Body height
- Property
- Len
- Time
- Pt
- System
- ^Patient
- Scale
- Qn
- Method
- Measured
Additional Names
- Short Name
- Body height Measured
Basic Attributes
- Class
- BDYHGT.ATOM
- Type
- Clinical
- First Released
- Version 1.0
- Last Updated
- Version 2.73
- Order vs. Observation
- Both
- Common Test Rank Get Info
- 372
Member of these Panels
LOINC | Long Common Name |
---|---|
76464-7 | American Physical Therapy Association registry panel |
39294-4 | Children's preventive health services attachment Set |
52745-7 | Continuity Assessment Record and Evaluation (CARE) tool - Post Acute Care (PAC) - Discharge |
52743-2 | Deprecated Continuity Assessment Record and Evaluation (CARE) tool - Acute Care |
52748-1 | Deprecated Continuity Assessment Record and Evaluation (CARE) tool - Home Health Admission |
52746-5 | Deprecated Continuity Assessment Record and Evaluation (CARE) tool - Interim |
69412-5 | Deprecated Continuity Assessment Record and Evaluation (CARE) tool - Long term care hospital (LTCH) - version 1.0 |
52744-0 | Deprecated Continuity Assessment Record and Evaluation (CARE) tool - Post Acute Care (PAC) - Admission |
83265-9 | Deprecated Inpatient Rehabilitation Facility - Patient Assessment Instrument (IRF-PAI) - version 1.4 [CMS Assessment] |
87414-9 | Deprecated Inpatient Rehabilitation Facility - Patient Assessment Instrument (IRF-PAI) - version 1.5 [CMS Assessment] |
88329-8 | Deprecated Inpatient Rehabilitation Facility - Patient Assessment Instrument (IRF-PAI) - version 2.0 [CMS Assessment] |
85645-0 | Deprecated Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 3.00 [CMS Assessment] |
45981-8 | Deprecated MDS full assessment form - version 2.0 |
46103-8 | Deprecated MDS quarterly assessment form - version 2.0 - optional version for RUG-III |
46104-6 | Deprecated MDS quarterly assessment form - version 2.0 - optional version for RUG-III 1997 update |
86522-0 | Deprecated MDS v3.0 - RAI v1.14.1 - Nursing home comprehensive (NC) item set [CMS Assessment] |
86872-9 | Deprecated MDS v3.0 - RAI v1.14.1 - Nursing home discharge (ND) and Swing bed discharge (SD) item set [CMS Assessment] |
86871-1 | Deprecated MDS v3.0 - RAI v1.14.1 - Nursing home OMRA start of therapy and discharge (NSD) and Swing bed OMRA start of therapy and discharge (SSD) item set [CMS Assessment] |
86873-7 | Deprecated MDS v3.0 - RAI v1.14.1 - Nursing home OMRA-discharge (NOD) and Swing bed OMRA-discharge (SOD) item set [CMS Assessment] |
86856-2 | Deprecated MDS v3.0 - RAI v1.14.1 - Nursing home PPS (NP) and Nursing home quarterly (NQ) item set [CMS Assessment] |
86876-0 | Deprecated MDS v3.0 - RAI v1.14.1 - Swing bed PPS (SP) item set [CMS Assessment] |
88282-9 | Deprecated MDS v3.0 - RAI v1.15.1 - Nursing home comprehensive (NC) item set [CMS Assessment] |
88283-7 | Deprecated MDS v3.0 - RAI v1.15.1 - Nursing home discharge (ND) and Swing bed discharge (SD) item set [CMS Assessment] |
88284-5 | Deprecated MDS v3.0 - RAI v1.15.1 - Nursing home OMRA start of therapy and discharge (NSD) and Swing bed OMRA start of therapy and discharge (SSD) item set [CMS Assessment] |
88285-2 | Deprecated MDS v3.0 - RAI v1.15.1 - Nursing home OMRA-discharge (NOD) and Swing bed OMRA-discharge (SOD) item set [CMS Assessment] |
88287-8 | Deprecated MDS v3.0 - RAI v1.15.1 - Nursing home PPS (NP) item set [CMS Assessment] |
88292-8 | Deprecated MDS v3.0 - RAI v1.15.1 - Nursing home quarterly (NQ) item set [CMS Assessment] |
88288-6 | Deprecated MDS v3.0 - RAI v1.15.1 - Swing bed PPS (SP) item set [CMS Assessment] |
88954-3 | Deprecated MDS v3.0 - RAI v1.16.1 - Nursing home comprehensive (NC) item set [CMS Assessment] |
88945-1 | Deprecated MDS v3.0 - RAI v1.16.1 - Nursing home discharge (ND) and Swing bed discharge (SD) item set [CMS Assessment] |
88946-9 | Deprecated MDS v3.0 - RAI v1.16.1 - Nursing home OMRA start of therapy and discharge (NSD) and Swing bed OMRA start of therapy and discharge (SSD) item set [CMS Assessment] |
88947-7 | Deprecated MDS v3.0 - RAI v1.16.1 - Nursing home OMRA-discharge (NOD) and Swing bed OMRA-discharge (SOD) item set [CMS Assessment] |
88949-3 | Deprecated MDS v3.0 - RAI v1.16.1 - Nursing home PPS (NP) item set [CMS Assessment] |
88955-0 | Deprecated MDS v3.0 - RAI v1.16.1 - Nursing home quarterly (NQ) item set [CMS Assessment] |
88950-1 | Deprecated MDS v3.0 - RAI v1.16.1 - Swing bed PPS (SP) item set [CMS Assessment] |
54580-6 | Deprecated Minimum Data Set - version 3.0 |
86189-8 | Deprecated Outcome and assessment information set (OASIS) form - version C2 - Resumption of care [CMS Assessment] |
85907-4 | Deprecated Outcome and assessment information set (OASIS) form - version C2 - Start of care [CMS Assessment] |
43142-9 | Height measurement device panel |
47245-6 | HIV treatment form Document |
75885-4 | IEEE 11073 Rosetta panel |
62611-9 | PhenX domain - Respiratory |
81232-1 | Supersaturation panel - 24 hour Urine |
86347-2 | U.S. standard certificate of live birth - recommended 2003 revision set |
86346-4 | U.S. standard report of fetal death - recommended 2003 revision set |
43143-7 | Weighing device panel |
Member of these Groups Get Info
LOINC Group | Group Name |
---|---|
LG34373-7 | Body height| |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
de-DE | German (Germany) | Körpergröße: |
es-AR | Spanish (Argentina) | altura corporal: |
es-MX | Spanish (Mexico) | Peso corporal: |
fr-FR | French (France) | Taille du patient: |
fr-BE | French (Belgium) | Taille corporelle: |
fr-CA | French (Canada) | Taille: |
it-IT | Italian (Italy) | Altezza corporea: Synonyms: Altezza del corpo - atomica Lunghezza paziente Punto nel tempo (episodio) |
nl-NL | Dutch (Netherlands) | lichaamslengte: Synonyms: lengte |
pt-BR | Portuguese (Brazil) | Estatura: Synonyms: ; |
ru-RU | Russian (Russian Federation) | Рост: Synonyms: Длина Количественный Тело высота Точка во времени; |
zh-CN | Chinese (China) | 身高: Synonyms: 一般体长; |
Example Units
Unit | Source |
---|---|
[in_us];cm;m | Example UCUM Units |
45257-3 Date dropped from HIV treatment
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Date dropped from HIV Rx
- Property
- Date
- Time
- Pt
- System
- ^Patient
- Scale
- Qn
- Method
- Reported
Additional Names
- Short Name
- Date dropped from HIV Rx
Basic Attributes
- Class
- ART
- Type
- Clinical
- First Released
- Version 2.17
- Last Updated
- Version 2.67
Member of these Panels
LOINC | Long Common Name |
---|---|
47245-6 | HIV treatment form Document |
Copyright
- Organization
- World Health Organization (WHO)
- Copyright
- Copyright © 2006 World Health Organization.
- Terms of Use
- Used with permission. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: bookorders@who.int). Requests for permission to reproduce or translate WHO publications - whether for sale or for noncommercial distribution - should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: permissions@who.int). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use.
- URL
- https://www.who.int/about/policies/publishing/copyright
31211-6 Date of death
Type of Entry
Question expects user entry - requires response [Q]
Fully-Specified Name
- Component
- Date of death
- Property
- TmStp
- Time
- Pt
- System
- ^Patient
- Scale
- Qn
- Method
Additional Names
- Short Name
- Date of death
Basic Attributes
- Class
- TUMRRGT
- Type
- Clinical
- First Released
- Version 2.07
- Last Updated
- Version 2.56
HL7® Attributes
HL7® Field ID- PID-29
Member of these Panels
LOINC | Long Common Name |
---|---|
78000-7 | Case notification panel [CDC.PHIN] |
75199-0 | Congenital syphilis case investigation and report panel [CDC.CS] |
52747-3 | Continuity Assessment Record and Evaluation (CARE) tool - Expired |
68359-9 | End Stage Renal Disease (ESRD) Death Notification - OMB CMS form 2746 |
47245-6 | HIV treatment form Document |
48547-4 | Omaha System 2005 panel |
85057-8 | PCORnet Common Data Model set - version 3.0 [PCORnet] |
86345-6 | U.S. standard certificate of death - recommended 2003 revision set |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
es-AR | Spanish (Argentina) | fecha de fallecimiento: |
es-MX | Spanish (Mexico) | Fecha de muerte: |
it-IT | Italian (Italy) | Data di morte: Synonyms: paziente Punto nel tempo (episodio) Registro tumori Time stamp (Data e Ora) |
pt-BR | Portuguese (Brazil) | Data da morte: Synonyms: Expired date; |
ru-RU | Russian (Russian Federation) | Дата смерти: Synonyms: Time Stamp (Дата и Время) Количественный Точка во времени; |
zh-CN | Chinese (China) | 死亡日期: Synonyms: NAACCR 肿瘤登记; |